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Soro animal é usado em cultivo celular por causa de seus fatores 
nutricionais, porém, seu uso é um risco potencial à saúde, devido a possível 
presença de agentes adventícios, tais como vírus e príons, e também é um dos 
principais responsáveis por reações alérgicas em cães. Células BHK-21 
adaptadas à suspensão crescendo em meio de cultura padrão com 3% de soro 
fetal bovino foram submetidas à adaptação em meio de cultura livre de soro. 
Os meios de cultura livre de soro usados neste estudo foram VP-SFM, Ex-Cell 
302 e Cellvento BHK-200. As células foram adaptadas ao VP por trocada direta 
do meio de cultura, ao Ex-Cell por troca direta e gradual do meio. Adaptação a 
Cellvento só foi possível usando células previamente adaptada a VP-SFM. As 
células adaptadas ao meio de cultura Ex Cell 302 apresentaram melhores 
resultados de crescimento. Todas as células adaptadas são capazes de 
produzir vírus da raiva. Porém, células adaptadas em VP-SFM apresentaram a 
melhor produtividade viral. Entretanto, produção de vírus utilizando Cellvento 
BHK-200 apresenta o melhor potencial econômico. 
Palavras chaves: vacina antirrábica veterinária, meio de cultura livre de soro, 








Animal serum is used in cell culture because of its nutritional factors, 
however, their use not only is a potential risky for health, due to possible 
presence of adventitious agents, such as virus and príons, but also is the major 
responsible of allergic reactions in dogs. BHK-21 cells adapted to suspension 
growing in standard culture media with 3% of fetal bovine serum were submitted 
to adaptation to serum free culture media. Serum free culture media used in this 
study were VP-SFM, EX-CELL 302 and Cellvento BHK-200. Cells were adapted 
to VP by direct media change, to Ex Cell by direct and gradual media change. 
Adaptation to Cellvento was only possible by using cells priory adapted to VP-
SFM. Cells adapted to Ex Cell culture media presented best growth results. All 
adapted cells have ability to produce rabies virus. Although, cells adapted to 
VP-SFM presented best virus productivity. However, virus production using 
Cellvento BHK-200 presents best economic potential.  
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Federal University of Paraná (UFPR) is the oldest University in Brazil. 
UFPR is reference in higher education for the Paraná State and for Brazil, 
because of importance and Excellence of graduation, undergraduate, 
specialization, master and doctoral courses, which are guided by the principle of 
indivisibility of Teaching, Research and Extension.  
The Department of Bioprocess Engineer and Biotechnology of UFPR, 
through its graduation and undergraduate courses (master, doctoral and post-
doctoral) has strong international integration, as well as strong partnerships with 
universities and research institutes in several countries. The course has among 
its specific objectives, qualify technical professionals and managers with skills 
and competencies to participate actively and interdisciplinary in activities of 
industrial biotechnology. These professionals are specialized in research and 
development of new products, especially in areas of Agribusiness and Agrifood 
Biotechnology and Human and Animal Health. In the field of human and 
veterinary health, this department has developed different projects in 
partnership with Tecpar. 
Technology Institute of Paraná (Tecpar) is a government company that 
performs research, development and innovation. In the field of industrial 
biotechnology plays an important role on the public health, as supplier of 
veterinary rabies vaccine for government mass vaccination. Besides, produces 
tetanus protein to be conjugated to bacterial triple vaccine, kits for diagnostic of 
zoonosis, and more recently, kits for detection of HIV and HCV in transfusional 
blood.  
Rabies vaccine laboratory has had important role in rabies prophylaxis in 
Brazil. In decade of 1970, Tecpar started large scale production of rabies 
vaccine for human and veterinary use, based on nerve tissue technology, using 
Fuenzadlida & Palacios methodology, to supply Ministry of Health for 
vaccination campaigns. Since dog mass vaccination started in Brazil, canine 
cases reduced 90%. In 2013, Tecpar has received permission from Ministry of 
Agriculture, Livestock and Supply to produce in large scale rabies vaccine using 
cell cultivation platform.  






Rabies is an acute encephalitis or meningoencephalitis due to a lyssavirus 
infection1. It is known to be present on all continents except Antarctica. All warm 
blooded animals are susceptible to rabies.  It enters the body through wounds 
or by direct contact with mucosal surfaces. Rabies virus replicates in the bitten 
muscle and gains access to motor endplates and motor axons to reach the 
central nervous system (Figure1)2,3. Most of the deaths occur in the absence of 
post-exposure prophylaxis.  
In more than 99% of all human rabies cases, virus is transmitted from 
dogs. Half of the global human population lives in canine rabies-endemic 
areas4. The most cost-effective strategy for preventing rabies in people is by 
eliminating it in dogs.  
Canine rabies can be eliminated, as it has been demonstrated in North 
America, Western Europe, Japan and many areas in South America. However, 
canine rabies is still widespread, occurring in over 80 countries and territories, 
which are predominantly in the developing world. Mass parenteral vaccination 
programs remain the mainstay of canine rabies control. Coverage of 70% of 
dog populations has been sufficient to control canine rabies in several settings4. 
First rabies vaccine was developed by Pasteur in 1885. It was composed 
of crude suspensions of desiccated, infected brain and spinal cord of rabbit, 
sheep or goat brain. Occasionally Pasteur’s vaccine led to vaccine-induced 
rabies5. Viral inactivation methods using phenol or betapropiolactone had been 
developed, increasing safety in vaccination, however, nerve-tissue vaccines 
enhance allergic neuroparalytic accidents caused by encephalitogen associated 
with myelin in adult mammalian brain, these reactions range from transient to 
severe paralysis, in some cases resulting in death5. 
 A significant reduction in neuroallergic side-effects was obtained with 
vaccine prepared in suckling mouse brain and inactivated with ultraviolet light or 
betapropiolactone6. It is imperative in the case of mouse suckling that they are 
under 9 days of age at the time of harvest5. 
After the 1950s, establishment of cell culture technology allowed 
significant progress in propagation of virus in vitro and consequent development 





technology have demonstrated to be safer and more immunogenic than nerve-
tissue vaccines8.  
 





Since 1984, World Health Organization (WHO) has recommended 
discontinuation of production and use of nerve-tissue vaccines and their 
replacement for cell culture vaccines1. In Brazil, nerve tissue vaccine was 
replaced by cell culture vaccine in 20021 for human public vaccination and in 
2010 for veterinary mass vaccination.  
Industrial production of viral vaccines preferably requires use of 
continuous or immortalized cell lines as the basis for viral multiplication7. For 
human rabies vaccine production, Vero cell line is the most widely used. For 
veterinary vaccine production cell lines used are baby hamster kidney cell line 
(BHK-21) or embryo hamster cell line (NIL2) 9-12.  
The BHK-21 cell line was isolated from five 1-day-old hamsters11 and 
consists of adherent fibroblasts that can also be adapted to suspension 
culture13. Suspension culture is widely used for veterinary vaccine production, 
due to lower costs of production and large cell quantities attained without need 





Effective in vitro maintenance and growth of animal cells requires culture 
conditions similar to those found in vivo with respect to temperature, oxygen 
concentrations, pH, osmolality, and nutrients14. 
Culture medium composition is one of the most important factors in culture 
of animal cells. Its function is to provide appropriate pH and osmolality for cell 
survival and multiplication, as well as supplying all chemical substances 
required by the cells that they are unable to synthesize themselves14.  
Some of these substances can be provided by a culture medium 
consisting of low molecular weight compounds, known as basal media. 
However, most basal media fail to promote successful cell growth by 
themselves and require supplementation with more complex and chemically 
undefined additives such as blood serum14. 
Fetal bovine serum (FBS) is the most frequently employed serum in 
animal cell culture however calves, horses, and even human sera are also 
used14. 
FBS is the favorite because it presents low immunoglobulin and high 
growth factor concentrations. However, it is one of the most expensive 
components in culture medium14. 
Use of serum in cell culture is important because of nutritional factors, 
culture-stimulating  factors (growth factors, hormones and proteins) and 
protecting agents, both for biological protection (antitoxin, antioxidant, 
antiprotease) and for prevention of mechanical damage14. 
However, using animal serum is potential risky for health, due to the 
possible presence of adventitious agents, such as virus and prions. In addition, 
serum can contain contaminants such as bacteria, fungi, and mycoplasmas, 
which can negatively affect cell culture. Another strong limitation to the use of 
sera is its variability among different lots and suppliers, which hinders the 
standardization of the culture medium and the reproducibility of culture 
performance14.  
Furthermore, studies have demonstrated that bovine serum is the major 
responsible of allergic reactions in dogs15. A research was designed to 
investigate the relationship between IgE reactivity to the vaccines and 
immediate-type allergic reactions after vaccination in dogs. Sera from 10 dogs 





cyanosis, dyspnea, facial edema, and vomiting within 1 hour after vaccination 
with rabies vaccines and sera from 50 dogs that did not develop allergic 
reactions after vaccination were collected. Then, IgE reactivity to fetal bovine 
serum and stabilizer proteins included in the vaccines was measured in sera 
that had high levels of IgE to the vaccines. Of the eight dogs that developed 
immediate-type allergic reactions and had high levels of serum specific IgE to 
the vaccines, seven had specific IgE directed to fetal bovine serum15.  
Later, researchers investigated IgE-reactive components of fetal bovine 
serum using sera from 16 dogs that exhibited allergic reactions after 
vaccination. The immunoblot analysis revealed that several fetal bovine serum 
proteins strongly reacted with IgE in the sera from dogs that showed post-
vaccination allergic reactions. The 66-kDa band was detected in the sera from 
14 of the 16 dog serum samples analyzed in the immunoblot analysis for fetal 
bovine serum, and it was speculated to be albumin based on its molecular 
weight, however, serum IgE reactivity to bovine serum albumin could be 
detected in only four of the 14 dog samples. These findings demonstrated that a 
variety of fetal bovine serum components including albumin could function as 
allergens in dogs that developed allergic reactions after vaccination. 
Many attempts have been made to develop culture media that do not need 
serum supplementation, that is, serum free media (SFM) formulations. One of 
the greatest difficulties is to design a culture medium that ensures replicate 
cultures that show stable genetic, metabolic, and kinetic behavior14.  
Despite all the development seen, up to the present time, there is no 
standard culture medium that could be universally utilized for all cells, since 
each cell line has a specific metabolic profile and requires an appropriate 
medium composition14.  
For instance, Cellvento™ BHK-200 medium is a serum free medium, 
formulated without any animal derived component and optimized for the culture 
of suspension BHK-21 cells at high-density, viability and efficient propagation of 
viruses. The medium formulation was developed for the growth and 
maintenance of BHK-21 suspension cell lines used for viral vaccine production, 
and qualified for the production of Foot and Mouth Disease virus (FMDV) 27. 
Ex Cell® 302 is a serum free medium which has been specifically 





(CHO) cells in suspension for the expression of antibodies or protein products. 
It was developed using only recombinant human proteins that have molecular 
weights less than 10 kDa28.  
VP-SFM™ is a serum free media expressly designed for virus production, 
manufactured without any components of animal or human origin. VP-SFM is a 
ultra-low protein medium designed specifically for the culture of Vero cells. It is 
also appropriate for the growth of COS-7, MDCK and BHK-21 in suspension. It 
is particularly suitable for growing viruses29. 
When using a new medium the need for cell adaptation should be 
considered. The assessment of cellular performance in different culture media 
is usually challenging and time-consuming, since it requires establishment of 
the concentration of total and viable cells, over multiple subcultures. In addition 
it may involve the quantification of residual nutrients, such as glucose and 
glutamine, of metabolic byproducts, such as lactate, ammonium and alanine, 
and the concentration of the target product14. 
Cell adaptation is often carried out in static cultures employing tissue 
culture flasks. However, problems seen at the time of adaptation can be 
minimized in suspension cultures, since this allows subculture during the log 
growth phase. Cultures in suspension also allow better medium oxygenation14 
and homogeneity.  
Mammalian cells can be adapted to serum free conditions by direct 
adaptation from serum containing media or gradual weaning. Both procedures 
require healthy, viable cultures in the mid logarithmic growth phase. During the 
adaptation phase, growth rates will usually be somewhat slower than growth in 
media supplemented with serum. 
Perrin et al, 199520 adapted BHK-21 cells to grow in MDSS218 serum free 
media, for production of an experimental rabies vaccine. Kallel et al, 200219 also 
adapted BHK-21 cell line to grow in different commercial serum free media and 
evaluated rabies vaccine produced. In both cases, adaptation was carried out 






2. Aim and objectives 
2.1. Aim 
To develop a process of production of rabies virus to rabies veterinary 
vaccine, using BHK-21 cell line in suspension adapted to commercial serum 
free media. 
2.2. Specific objectives 
 Adapt BHK-21 cell line to grow in different commercial serum free media; 
 Analyze growth kinetics of adapted cells; 
 Infect cells with rabies virus and analyze behavior of infected cells; 
 Verify virus production capacity of serum free media adapted cells; 






3. Material and methods 
 
3.1. Culture media 
Standard culture medium (SCM), comprising DMEM/Ham’s F12 1:1 
supplemented with 3% of FBS, was used for control cell culture. 
Standard culture medium for infection (SCMI), comprising DMEM/Ham’s 
F12 1:1 supplemented with 1% of FBS, was used during virus infection of 
control cell culture. 
The following serum free media VP-SFM™ (Gibco – Invitrogen cell 
culture), Ex-Cell® 302 (SAFC Biosciences) and Cellvento™ BHK-200 (Merck 
Millipore) were used. Media were prepared following manufacturer’s 
instructions. No antibiotic was added. 
Cryopreservation culture media were prepared using 7% of DMSO, 46.5% 
serum free media and 46.5% media supernatant of centrifuged cells for 
cryopreservation. 
 
3.2. Cell line 
BHK-21 C13 LVI cell line, adapted to suspension, in passage 118, 
provided from Tecpar working cell bank, was used. Tecpar BHK-21 C13 LVI cell 
bank was originated from Panaftosa with 84 passages, cells were adapted to 
grow at SCM to generate master and working cell bank. Cells were stored at -
196°C. 
 
3.3. Virus strain 
Rabies Pasteur Virus (PV) supplied from Federal University of Minas 
Gerais (UFMG) was adapted to grow in BHK-21 C13 in suspension. Adapted 
virus generate Tecpar master and working virus bank, stored at -80°C. Virus 
strain was provided from Tecpar working virus bank was used for this study. 
 
3.4. Cell adaptation strategies 
Three different cell adaptation protocols were used:  
 
3.4.1. Direct medium change (D): cell line growing healthily in SCM, 





resuspended in serum free media at concentration of 
2.0x105cells/mL (Figure 2). Subcultures were made until cell 
adaptation. 
 
3.4.2. Gradual medium change (G): cell line growing healthily in SCM, 
with cell density higher than 7.5x105cells/mL, had serum free media 
added in culture gradually during subculture (Figure 2). Increased 
quantity of serum free media was only added when cell was growing 
healthily in previous adaptation phase. In last adaptation step, cells 
were centrifuged, in order to remove all serum from cultivation, and 
resuspended in serum free media. 
 
3.4.3. Gradual serum reduction (S): cell line growing healthily in SCM, 
with cell density higher than 7.5x105cells/mL, was centrifuged and 
resuspended in serum free media at concentration of 
2.0x105cells/mL. SFM was supplemented with 3% of fetal bovine 
serum. Serum was decreased from culture gradually during 
subcultures (Figure 2). Serum was only reduced when cell had 
normal growth at previous adaptation phase. In last adaptation step, 
cells were centrifuged, in order to remove all serum from cultivation, 
and resuspended in serum free media. 
 
During adaptation a control culture in SCM was held to compare growth 
behavior. 
If cells, during adaptation, did not grow as control, half of volume media 
was replaced (by centrifugation) for fresh medium. This procedure was used to 
offer better conditions for cell growth (adding nutrients and removing inhibitory 
metabolites). 
Direct media change protocol was used for adaptation of three serum free 
culture media used in this study. Gradual media change protocol was used to 
adapt cells to VP-SFM and Ex-Cell 302 serum free media. Gradual serum 
reduction protocol was used to adapt cells to Cellvento BHK-200 serum free 





FIGURE 2 – PROTOCOLS USED FOR CELL ADAPTATION TO SERUM FREE MEDIA 
 
3.5. Cell cultivation 
Cell cultivation was performed in spinner flasks (Techne, United Kingdom) 
of 500mL working volume, with 400mL of culture medium, incubated at 37°C 
and agitated at 55rpm. Innoculum was made with cell density of 
2.0x105cells/mL. Subcultures (cells dilution) were made when growth reached 
7.5x105cell/mL or higher density. 
Sometimes, during adaptation to SFM, even when cells did not reach 
7.5x105cells/mL, a subculture was done, usually to try to enhance growth 
conditions. Also, if cells could not reach cell density higher than 
7.5x105cells/mL, innoculum for subculture was increased to 5x105cells/mL, to 
try making cells reach higher density. 
Samples were collected daily for cell count, viability determination, 
morphology verification, metabolites analysis and pH measurement. 
 
3.6. Cell count 
Cell samples were diluted and stained with trypan blue (0.5%) than 
counted in hemocytometer. Viable cells present intact membrane, and are not 
colored by trypan blue, not viable cells permit trypan blue to traverse 
 
    
    
      
               
                                                 
    
        
        
        
         
                     
    
    
                           
          
            
             
            
                    
             




membrane, being colored by dyer. Total cells, viable cells and cell viability were 
determined. Morphology, light refringence and size were evaluated. 
 
3.7. Metabolism analysis 
Glucose consumption and lactate production were determinate to verify 
growth limitation by inhibitory levels of lactate or by glucose scarcity.  
A dual channel biochemical analyzer YSI 2700 (Yellow Spring 
Instruments, EE.UU.) was used for glucose and lactate determination. Each 
channel contains immobilized enzyme on a polycarbonate membrane. One 
membrane has enzyme glucose oxidase immobilized and catalyzes the 
following reaction: 
glucose + O2 + H2O → gluconic acid + H2O2   (reaction 1) 
In other membrane, the enzyme lactate oxidase catalyzes reaction 2: 
lactate + O2  → piruvate + H2O2        (reaction 2) 
Hydrogen peroxide generated independently in each membrane is 
oxidized in a platinum anode. Electron flow is linearly proportional to 
concentration of hydrogen peroxide formed, and this, to the concentration of the 
substance in the sample. Variation of 2% was considered acceptable between 
successive calibrations. 
 
3.8. Sedimentation tests 
Cell lines adapted to serum free media were submitted to sedimentation 
tests. It consists of taking cell culture, with cell density over than 
7.5x105cells/mL, in cold chamber (2-8°C) for 2 or 3 hours until complete cell 
sedimentation. Carefully, culture media was removed from spinner (about 200 
mL) and fresh media was added. This procedure was repeated during 3 
consecutive days. Every day, samples were collected to cell count, viability, 
morphology and metabolic analysis. To be approved in this test, cells should 




Sedimentation test was performed to simulate industrial rabies virus 
production where cells have to be sedimented for virus infection. So, adapted 
cells should be robust enough for this operation. 
 
3.9. Cryopreservation  
Seed banks were made with cell lines approved in sedimentation tests. 
Cryotubes with 1x107cells and 1mL of cryopreservation media were frozen in -
80°C freezer. Gradual temperature reduction rate of -1°C/minute was achieved 
using Mr. Frosty (Nalgene) and isopropyl alcohol. After reaches -80°C, cells 
were stored at liquid nitrogen (-196°C).  
 
3.10. Growth kinetics 
Cell cultivation was performed with 400mL of culture medium at 37°C, in 
spinner flasks of 500mL working volume (Techne, United Kingdom), agitated at 
55rpm, innoculum was made with cell density of 2.5x105. No subculture was 
done. Daily, samples were collected for cell count, viability determination, 
morphology verification, metabolites analysis and pH measurement. Cultivation 
was carried out until cells death. 
Specific growth rate, µ (cells/h), was estimated by the following equation19: 
 
µ= (LnX2 – LnX1)/(t2 – t1)       (equation 1) 
 
Where, X represents the viable cell density per mL, t represents the time 
points of sampling expressed n hours; the subscripts 1 and 2 stand for two 
succeeding sampling points. 
 
3.11. Cell infection and virus production 
Cell infection was carried out on cultures with cell density of about 
1.0x106cells/mL. pH was adjusted to 7.4, with sodium bicarbonate 7.5%, cells 
were sedimented in cold chamber, 300mL of media was removed. Virus, in 
multiplicity of infection (MOI) of 0.015, and DEAE (1% of final volume) were 




rpm agitation (5 minutes of agitation, 20 minutes stopped) during 90 min. 
Infection media was added and spinners were again incubated at 33°C over 
55rpm. 
Daily, samples were collected for cell count, metabolites analysis, pH 
measurement, virus titer determination and direct immunofluoresce assay. pH 
was adjusted, to 7.4, cells were sedimented on cold chamber and half volume 
of media was harvested. Fresh media was added and spinners were again 
incubated. This procedure was held for 6 days. 
 
3.12. Direct Immunofluorescence assays 
Infected cells samples (50 µL) were sedimented in microscope slides, 
fixed with cold 80% acetone and stained with Evans Blue dye (1:40000) and 
flurescein-labeled antirabies nucleocapsid immunoglobulins (Bio-rad code 357-
2114). Slides were analyzed in fluorescence microscope to determine level o 
cell infection. It was evaluated in terms of fluorescent focus inside the cells 
(Table 1). This procedure was adapted from Batista and collaborators, 200920. 




TABLE 1 – RELATION BETWEEN INFECTION CLASS AND FLUORESCENCE 
FOCUSES 
Infection class Fluorescence focus 
0 total absence of fluorescent focuses 
I 1 to 25% of cells had fluorescence focuses 
II 26 to 50% of cells had fluorescence focuses 
III 51 to 75% of cells had fluorescence focuses 
IV 76 to 100% of cells had fluorescence focuses 
 
 
3.13. Rabies virus titration 
For determination of rabies virus titer 21-23, monolayers of BHK-21 cells on 
96 well microtiter plates were infected with sample dilutions and incubated at 
37°C with 5% CO2 for 22h. Cells were then fixed with cold 80% acetone, 




labelled antirabies nucleocapsid immunoglobulins (Bio-rad code 357-2114) for 
1h at 37°C. The microtiter plates were then observed in fluorescence 
microscope and titer was expressed as fluorescent focus doses 50 (FFD50) as 






4. Results and discussion 
 
4.1. Cell adaptation 
Table 2 presents strategies used for cell adaptation. Strategies were used 
following manufacturer’s recommendations. 
In each adaptation, a control culture with standard culture media (SCM) 
was carried out to compare results. 
 
TABLE 2 – STRATEGIES USED FOR BHK-21 CELL LINE ADAPTATION TO SERUM FREE 
MEDIA 
Adaptation strategy Serum free media 
VP Ex Cell 302   Cellvento 
BHK-200 
Direct media change (D) X X X 
Gradual media change (G) X X  
Gradual serum reduction (S)   X 
 
4.1.1. Adaptation to VP-SFM from SCM 
 
 Control culture 
Control culture presented a standard behavior (Figures 3A and 3B) during 
subcultures. Cell morphology, size and refringence were normal. Cell density 
reached 7.5x105/mL or higher after two days of cultivation, cell viability was 
higher than 80%, usually, cells doubled or tripled every day. Glucose 
consumption, lactate production and pH values were very similar during 
subcultures.  
 
 Direct Medium Change 
In adaptation using direct media change from SCM to VP (VPD), during 18 
days and 10 subcultures, cells presented abnormal morphology, size and 
growth (Figure 4A). In some subcultures, cells have grown in clumps. There 
was much cell debris in medium and viability was very low, reaching 18% in 
fourth adaption day. In this period, between some subcultures, cells were 
centrifuged and half of culture media was replaced, in order to remove inhibitory 
metabolites, adjust pH and supply nutrients. In eleventh subculture, cells started 





formed aggregates, so 3 more subcultures were carried out, to confirm cells 
behavior (Figures 4A and 4B). As cells maintained behavior, and clumps were 
not formed anymore, cells were submitted to sedimentation test. During 
sedimentation test, no clump was formed and culture reached density of 
1.8x106 cells/mL. Cells were considered adapted to VP-SFM culture media and 
robust enough to virus production. Seed bank was made.  
Adaptation to VP-SFM took 26 days and 15 passages.  
 
 Gradual Medium Change 
In adaptation using gradual media change from SCM to VP (VPG), first 
step of media change was 75% of SCM and 25% of VP, no alteration in cell 
behavior or metabolites was observed (Figures 5A and 5B), after 3 subcultures, 
a new step of  media substitution was done, 50% of SCM and 50% of VP. No 
alteration in cell behavior or metabolites was observed. Next step was 25% of 
SCM and 75% of VP. In this step, cell viability and cell growth decreased during 
third and fourth subcultures, but in next passage, cell growth behavior became 
normal and cell viability improved in sixth subculture. So next media change 
step was done: 0% of SCM and 100% of VP. In this adaptation stage, cells 
morphology was abnormal, clumps were formed, and much cells debris was 
observed in media. In some subcultures, cells were centrifuged and half of 
culture media was replaced in order to remove inhibitory metabolites, adjust pH 
and supply nutrients. Even though, no improvement in cells morphology was 
observed, and also, glucose consumption and lactate production were higher 
than during prior adaptation steps and control cells. As adaptation in direct 
media change was reached. This adaptation procedure was stopped, and cells 
were not considered adapted.  







Cell adaptation - control 
    
FIGURE 3 – ADAPTATION TO VP SERUM FREE MEDIA: CONTROL CULTIVATION. 
Growth (A) and metabolites (B) behavior of control BHK-21 cell line, in SCM. Cultivation was carried out 
during adaptation of BHK-21 cell line to VP serum free media. 
 
Cell adaptation - VPD 
  
FIGURE 4 – ADAPTATION TO VP SERUM FREE MEDIA BY DIRECT MEDIA CHANGE. 
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to VP-SFM, by direct media 
change. 
Cell adaptation - VPG 
    
FIGURE 5 – ADAPTATION TO VP SERUM FREE MEDIA BY GRADUAL MEDIA CHANGE. 
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4.1.2. Adaptation to Ex Cell 302 from SCM 
 
 Control culture 
Control culture presented standard behavior (Figures 6A and 6B) during 
subcultures. Cell morphology, size and refringence were normal. Cell density 
reached 7.5x105 or higher after two days of cultivation, cell viability was higher 
than 80%, cells doubled or tripled every day. Glucose consumption, lactate 
production and pH values were very similar during subcultures.   
 
 Direct Medium Change 
In adaptation using direct media change from SCM to Ex Cell 302 (ExD), during 
26 days and 10 subcultures, cells presented abnormal morphology, size and 
growth (Figure 7A). There was much cell debris in medium but cell viability had 
not decreased as much as in VPD adaptation, lowest viability value was 72%. In 
this period, between some subcultures, cells were centrifuged and half of 
culture media was  replaced. In  eleventh  subculture, cells  started  to  present 
similar growth and metabolites behavior to control culture. Three more 
subcultures were done, to confirm cells behavior (Figures 7A and 7B). As cells 
maintained behavior, they were submitted to sedimentation test. During 
sedimentation test, no clump was formed and culture reached density of 
1.2x106cells/mL. Cells were considered adapted to Ex Cell 302 culture media 
and robust enough to process of virus production. Seed bank was made. 
Adaptation to Ex Cell 302 by direct media change took 36 days and 14 
passages.  
 
 Gradual Medium Change 
In adaptation using gradual media change from SCM to Ex Cell 302 
(ExG), first step of media change was 75% of SCM and 25% of Ex Cell 302, no 
alteration in cell growth behavior nor in metabolism was observed (Figures 8A 
and 8B), but cell morphology and size were abnormal and media had much 
cells debris. Even though, after 4 subcultures, a new step of media substitution 
was done, 50% of SCM and 50% of Ex Cell 302. No alteration in cell behavior 
or metabolites was observed, cell morphology and size became normal and 





In this step, 4 subcultures were done, cell growth behavior was normal, glucose 
consumption was higher, but can be explained due to higher cell density. So 
next media change step was done: 0% of SCM and 100% of Ex Cell 302. In this 
adaptation stage, no problem was observed. Morphology, growth and 
metabolites had same behavior that control cells. So, cells were submitted to 
sedimentation test: no clump was formed and culture reached density of 
1.3x106cells/mL. Cells were considered adapted to Ex Cell 302 culture media 
and robust enough to virus production. Seed bank was made.  
Adaptation to Ex Cell 302 by gradual media change took 36 days and 18 
passages. ExG adaptation took same time than ExD adaptation, but more 
subcultures were done, this is due to in ExD adaptation, cells took longer to 
reach cell density higher than 7.5x105. 
 
Cell adaptation - control 
   
FIGURE 6 – ADAPTATION TO EX CELL 302 SERUM FREE MEDIA: CONTROL 
CULTIVATION. 
Growth (A) and metabolites (B) behavior of control BHK-21 cell line, in SCM. Cultivation was 
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Cell adaptation - ExD 
   
FIGURE 7 – ADAPTATION TO EX CELL 302 SERUM FREE MEDIA BY DIRECT MEDIA 
CHANGE.  
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to Ex Cell 302 
serum free media, by direct media change. 
 
Cell adaptation - ExG 
   
FIGURE 8 – ADAPTATION TO EX CELL 302 SERUM FREE MEDIA BY GRADUAL MEDIA 
CHANGE.  
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to Ex Cell 302 
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4.1.3. Adaptation to Cellvento BHK-200 from SCM 
 
 Control culture 
Control culture presented standard behavior (Figures 9A and 9B) during 
subcultures. Cell morphology, size and refringence were normal. Cell density 
reached 7.5x105 or higher after two days of cultivation, cell viability was higher 
than 80%, cells doubled or tripled every day. In some subculture cells 
quadrupled in 24 hours. Glucose consumption, lactate production and pH 
values were very similar during subcultures.  
 
 Direct Medium Change 
In adaptation using direct media change from SCM to Cellvento BHK-200 
(CVTD), during 50 days and 15 subcultures, cells presented abnormal 
morphology, size and growth (Figures 10A and 10B). In some subcultures, cells 
have grown in clumps. There was much cell debris in medium. In this period, 
between some subcultures, cells were centrifuged and half of culture media was 
replaced, in order to remove inhibitory metabolites, adjust pH and supply 
nutrients. Even though, in no subculture, cells reached higher density than 
5.8x105cells/mL. No enhance in cell morphology or growth were observed with 
time, so this adaptation work was stopped without any cell adaptation. 
 
 Gradual Serum Reduction 
In adaptation using gradual serum reduction from SCM to Cellvento BHK-
200 (CVTS), first step was to centrifuge cells from SCM and resuspend cells in 
Celvento with 3% of FBS. In this step of adaptation, cells presented normal 
morphology, growth and metabolism (Figures 11A and 11B). Four subcultures 
were performed and first step of serum reduction was done (reduction to 1.5%). 
Cells also have presented normal morphology, growth and metabolism. So, 
after 3 subcultures, a new adaptation step was done: Cellvento supplemented 
with 0.75% of FBS. This step presented no problem with cell morphology, cell 
growth, or metabolism. Next step of serum reduction was carried out (Cellvento 
with 0.5% of FBS), but contaminated and had to be discharged (results not 





This step had not showed any cultivation problem. Cell growth, morphology and 
metabolites were similar to standard. 
In next step, Cellvento supplemented with 0.25% of FBS, cells started to 
show abnormal growth, in some subcultures, even with media replacement, 
they could not reach density of 7.5x105cell/mL. Cell innoculum was increased to 
5.0x105 cells/mL but cells could not double. Cell morphology became very 
irregular; media had much cells debris and different sizes of cells in culture.  
After 41 passages and 116 days trying to adapt cells work was stopped, 
without cell adaptation.  
As Cellvento BHK-200 is a culture media developed to be used in 
veterinary vaccine production, its price is about 10 times cheaper than other 
serum free media used in this study. Adaptation of BHK-21 to this media has a 
very important economic perspective. So failure in adaptation using previous 
strategies leads to try a new strategy. In this new strategy, cells already 
adapted to VP serum free media were used to adapt to Cellvento BHK-200. 
Two adaptation protocols were used direct media change and gradual media 
change. Below are presented results of this new protocol. 
 
Cell adaptation - control 
   
FIGURE 9 – ADAPTATION TO CELLVENTO BHK-200 SERUM FREE MEDIA: CONTROL 
CULTIVATION. 
Growth (A) and metabolites (B) behavior of control BHK-21 cell line, in SCM. Cultivation was 
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Cell adaptation - CVTD 
    
FIGURE 10 – ADAPTATION TO CELLVENTO BHK-200 SERUM FREE MEDIA BY DIRECT 
MEDIA CHANGE.  
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to Cellvento 
BHK-200 serum free media, by direct media change. 
 
Cell adaptation - CVTG 
    
FIGURE 11 – ADAPTATION TO CELLVENTO BHK-200 SERUM FREE MEDIA BY GRADUAL 
SERUM REDUCTION.  
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to Cellvento 
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4.1.4. Adaptation to Cellvento BHK-200 from VP-SFM 
 
 Control culture 
Control culture presented standard behavior (Figures 12A and 12B) during 
subcultures. Cell morphology, size and refringence were normal. Cell density 
reached 7.5x105 or higher after two days of cultivation, cell viability was higher 
than 80%, cells doubled or tripled every day. In some subcultures, cells 
quadrupled. Glucose consumption, lactate production and pH values were very 
similar during subcultures.   
 
 Direct Medium Change 
In adaptation using direct media change from VP to Cellvento BHK-200 
(CVTDvp), first two passages presented much cells debris, but cell morphology, 
size and refringence remained normal. During subcultures, cells could not reach 
density higher than 7.5x105, so in some subcultures innoculums with 5.0x105 
cells/mL were used, to make cells double and reach 1.0x106 cells/mL (Figures 
13A and 13B). In thirteenth subculture, cell density was 1.0x106cells/mL, from 
innoculum of 2.0x105cells/mL. Next two subcultures, cells maintained behavior, 
so, were submitted to sedimentation test. During sedimentation test, no clump 
was formed and culture reached density of 2.1x106cells/mL. 
After 42 days and 15 passages, cells were adapted to Cellvento BHK-200 
culture medium and robust enough to virus production process. 
 
 Gradual Medium Change 
In adaptation using gradual media change from VP to Cellvento BHK-200 
(CVTGvp), first step of media change was 75% of VP and 25% of Cellvento 
BHK-200, no alteration in cell growth behavior or metabolites was observed 
(Figures 14A and 14B), but in third passage cells grew in clumps. Even though, 
a new step of media substitution was done, 50% of VP and 50% of Cellvento 
BHK-200, no alteration in cell behavior or metabolites was observed. Next step 
was 25% of VP and 75% of Cellvento BHK-200. In this step, cells presented 
standard behavior. So next media change step was done, but, as adaptation to 
Cellvento failed in prior adaptation work, a more gradual media change was 





this adaptation stage, no problem was observed. A new adaptation step was 
performed, where, 5% of VP and 95% of Cellvento BHK-200 were used. As, in 
this step, subculture had density of 1.1x106cells/mL and viability of 99%, the last 
step was done, with 0% of VP and 100% of Cellvento BHK-200. Three 
subcultures were carried out, and no abnormal situation was detected. Cells 
were submitted to sedimentation test. During sedimentation test, no clump was 
formed and culture reached density of 1.9x106 cells/mL. Cells were considered 
adapted to Cellvento BHK-200 culture media and robust enough to virus 
production. Seed bank was made.  
Adaptation to Cellvento by gradual media change from cells adapted to VP 
took 42 days and 20 passages. CVTGvp adaptation took same time than 
CVTDvp adaptation, but more subcultures were done, this is due to in CVTDvp 
adaptation, cells took longer to reach cell density higher than 7.5x105. 
 
 
Cell adaptation - control 
   
FIGURE 12 – ADAPTATION TO CELLVENTO BHK-200 SERUM FREE MEDIA, USING CELLS 
ADAPTED TO VP-SFM: CONTROL CULTIVATION. 
Growth (A) and metabolites (B) behavior of control BHK-21 cell line, in SCM. Cultivation was 
carried out during adaptation of BHK-21 cell line to Cellvento BHK-200 serum free media, using 
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Cell adaptation - CVTDvp 
   
FIGURE 13 – ADAPTATION TO CELLVENTO BHK-200 SERUM FREE MEDIA BY DIRECT 
MEDIA CHANGE, USING CELLS ADAPTED TO VP-SFM.  
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to Cellvento 
BHK-200 serum free media, by direct media change, using cells previously adapted to VP-SFM. 
 
Cell adaptation - control 
   
FIGURE 14 – ADAPTATION TO CELLVENTO BHK-200 SERUM FREE MEDIA BY GRADUAL 
MEDIA CHANGE, USING CELLS ADAPTED TO VP-SFM.  
Growth (A) and metabolites (B) behavior of BHK-21 cell line, during adaptation to Cellvento 
BHK-200 serum free media, by gradual media change, using cells previously adapted to VP-
SFM. 
 
Table 3 presents a summary of cell adaptation to serum free media 
results. Considering that it was needed 26 days and 15 passages to adapt cells 
to VP-SFM, the actual value of passages to adapt BHK-21 cells to Cellvento 
BHK-200 culture media was 30 in direct media change, 35 in gradual media 
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TABLE 3 – SUMMARY OF CELL ADAPTATION TO SERUM FREE MEDIA. 
 Media exchange 
Adaptation strategy SCM→VP SCM→Ex Cell SCM→Cellvento VP→Cellvento 
Direct media change (D) 26 days           
15 
passages 




42 days           
15 
passages 
Gradual media change 
(G) not adapted 









- - not adapted - 
 
It was expected that in direct media change cells would adapt to new 
media without need of subcultures. This result was not got in any culture media 
used. At least 14 passages for Ex Cell 302 and 15 passages for VP were 
needed to have cells adapted. 
H. Kallel et al19 adapted BHK-21 cell line to three commercial serum free 
media, HyQ PF CHO, HyQ PF CHO MPS and Ex Cell 302 in a single step by 
direct switch from serum containing media, and adapted BHK-21 to Rencyte by 
gradual media change. In gradual adaptation 26 days were necessary for 
adaptation. In this study, cells grew in monolayer. After adaptation, cells were 
no longer adherent, but grew in suspension forming clumps.  
O. Merten et al18 adapted BHK-21 cells to serum free media MD SS2, 
using same protocol that Kallel and collaborators19 and cells also grew as 
clumps cultures. 
In both studies, clumps cultures were able to produce rabies virus, 
however, in aggregated culture, it is not possible to have homogeneity, cells in 
the middle of aggregates have difficulties to access nutrients, and it is more 
difficult to have virus infection. Besides, cells in clumps do not grow as healthy 
as cells free in suspension. So cells in suspension adapted to serum free 
medium without forming clumps are a great perspective to industrial use. 
 
4.2.  Growth kinetics 
 
Growth kinetics was carried out with all serum free adapted cell lines and 





As shown in Figure 15, BHK-21 cells growth in SCM reached maximal 
viable cell density of 8.1x105cells/mL in fourth day of cultivation. Glucose 
concentration was not limiting to growth nor lactate concentration reached 
inhibitory levels, following what was described by Cruz et al25. Cultivation lasted 
6 days, where, there was no lag phase, 2 days of exponential phase, 3 days of 
stationary phase and 1 day of death phase. Maximal specific growth rate 
obtained was 0.036h-1. As glucose and lactate were not limitation to growth, 
probably cells stopped to grow due to ammonia production or by absence of 
any other nutrient, such as glutamine. 
 
Growth Kinetics - Control 
 
FIGURE 15 – GROWTH KINETICS OF BHK-21 CELLS IN SCM.  
 
 
Cells adapted to VP-SFM, by direct media change (VPD) presented 1 day 
of lag phase, 1 day of log phase, 1 day of stationary phase and 2 days of death 
phase (Figure 16). Maximal cell density, 8.2x105viable cells/mL, was obtained 
on third day of cultivation.  Cultivation lasted  6 days,  just like control culture.   
Growth  was  not limited by glucose nor lactate concentration25. As log phase 
was more acute, maximal specific growth rate obtained 0.052h-1 was higher 
than control culture. Cells lasted less time in stationary phase, and cell death 
was more gradual than in control culture. Maximal cell density was the lowest 
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Growth Kinetics - VPD 
 




TABLE 4 – GROWTH OF BHK-21 CELLS IN SPINNER IN DIFFERENT SERUM 
FREE MEDIA AND DIFFERENT ADAPTATION STRATEGIES 









Control 0,81 0,036 6 
VPD 0,82 0,052 6 
ExD 2,09 0,113 13 
ExG 0,95 0,030 17 
CVTDvp 1,03 0,058 8 
CVTGvp 1,09 0,041 8 
 
 
Cells adapted to Ex Cell 302 serum free media, by direct media change 
(ExD) presented an atypical behavior. In first day of cultivation, cell density was 
1.95x106viable cells/mL, about 10 times higher than innoculum (Figure 17). 
Maximal specific growth rate was 0.113h-1, twice higher than highest obtained 
in other kinetics (Table 4). Maximal cell density, 2.09x106, was obtained on 
third cultivation day. This cultivation was the one with best energetic efficiency, 
since with similar glucose concentration available, higher cell density and lower 
lactate production were obtained, when compared with other growth kinetics. 
Glucose scarcity was obtained on fifth day, but cultivation lasted for 13 days, 
suggesting that other energy source, probably glutamine, was used during 
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BHK-21 cells to Ex Cell 302 serum free media, but maximal cell density 
obtained was 7x105cells/mL and maximal specific growth rate obtained was 
0.016h-1. This result suggests that protocol used for adaptation can interfere in 
cell growth behavior. 
 
Growth Kinetics - ExD 
 
FIGURE 17 – GROWTH KINETICS OF BHK-21 CELLS ADAPTED TO EX CELL 302 BY 
DIRECT MEDIA CHANGE 
 
Cells adapted to Ex Cell 302 serum free media, by gradual media change 
(ExG), reached maximal cell density, 9.5x105viable cells/mL, in thirteenth day 
(Figure 18). Cells growth was the slowest, with maximal specific growth of 
0.030h-1, however, it had the longest cultivation time, lasting 17 days. This 
cultivation had 1 day of lag phase, 2 days of exponential phase, 12 days of 
maintenance phase, and 2 days of senescence phase. This cultivation reached 
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Growth Kinetics - ExG
 
FIGURE 18 – GROWTH KINETICS OF BHK-21 CELLS ADAPTED TO EX CELL 302 BY 
GRADUAL MEDIA CHANGE. 
 
 
 Cells adapted to Cellvento BHK-200 media, by direct media change 
(CVTDvp) presented 1 day of lag phase, 3 days of log phase, no day in 
stationary phase and 4 days of death phase (Figure 19). Maximal cell density, 
1.03x106viable cells/mL, was obtained on fourth day of cultivation. Cultivation 
lasted 8 days, and growth was neither limited by glucose nor lactate 
concentration19. Maximal specific growth rate obtained was 0.058h-1.  
 
Growth Kinetics - CVTDvp 
 
FIGURE 19 – GROWTH KINETICS OF BHK-21 CELLS ADAPTED TO CELLVENTO BHK-200 
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Cells adapted to Cellvento BHK-200 serum free media, by gradual media 
change (CVTGvp) presented very similar behavior to CVTDvp.  One day of lag 
phase, 2 days of log phase, no day in stationary phase and 5 days of death 
phase  (Figure 20). Maximal cell density, 1.09x106viable cells/mL, was obtained 
on third day of cultivation. Cultivation lasted 8 days, and growth was neither 
limited by glucose nor by lactate concentration. Maximal specific growth rate 
obtained was 0.041h-1.  
 
Growth Kinetics - CVTGvp 
 
FIGURE 20 – GROWTH KINETICS OF BHK-21 CELLS ADAPTED TO CELLVENTO BHK-200 
BY GRADUAL MEDIA CHANGE, USING CELL PREVIOUSLY ADAPTED TO VP-SFM. 
 
 
Figure 21 shows a comparison among 6 kinetics studies. ExD cells 
cultivation obtained twice higher cell density and cultivation lasted twice longer 
than control cultivation. ExG cells cultivation lasted three times more than 
control culture with similar maximal cell density. Even though CVTDvp and 
CVTGvp did not have stationary phase, cells density were higher than control 
on 3rd to 6th cultivation days. VPD had maximal cell density similar to control 
culture, but cells deaths started earlier than control. 
In this study, it is possible to affirm that BHK-21 cells are better adapted to 
Ex Cell 302 serum free culture media, and direct media change adaptation lead 
















0 1 2 3 4 5 6 7 8

























Growth kinetics comparison 
 
FIGURE 21- GROWTH KINETICS COMPARISON OF ALL ADAPTED CELL LINES. 
 
4.3. Infection Kinetics 
All adapted cell lines were submitted to infection kinetics. Control culture 
was carried out using SCMI. 
During all infection kinetics studies, maximal cell densities of cultivations 
were obtained after infection, due to media harvest that provided nutrient and 
removed metabolites. In control cultivation, Figure 22A, cell viability decreased 
right after cell infection (total cells density became higher than viable cells 
density). Glucose and lactate metabolism after infection was very similar to 
metabolism of non infected cells (Figure 15). Since second day post infection 
(dpi), more than 75% of cells were infected. Titer peak (bold in Table 5) 
coincided with maximal cell density (Figure 22B), in third dpi.  
Taking into account that in Tecpar, only harvest with log10 FFD50 higher 
than 3.8 are used to veterinary vaccine production, first harvest was the only 
one that does not meet this requirement (Table 5).  
 
 




Rabies virus titer log10 FFD50/mL 
1dpi 2dpi 3dpi 4dpi 5dpi 6dpi average 
Control 3,23 4,93 5,47 5,04 5,04 4,63 4,72 
VPD 4,90 5,25 5,54 5,54 5,62 5,11 5,33 
ExD 2,96 4,92 5,54 5,04 5,4 5,25 4,85 
ExG 2,83 4,91 4,9 5,32 4,9 5,18 4,67 
CVTDvp 3,53 4,63 4,9 5,32 5,32 4,64 4,72 
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Infection Kinetics - Control 
 
 
Cell density x Virus titer – Control 
 
FIGURE 22 – INFECTION BEHAVIOR, CELL GROWTH AND METABOLISM AFTER RABIES 
VIRUS INFECTION (A), AND VIRUS PRODUCTION (B) OF CONTROL CELLS.  
 
 
In Infection kinetics of VPD cells (Figure 23A), maximal cell density was 
2.3x106viable cells/mL. Cell viability decreased only after third dpi. Cells 
infection class IV was obtained on third dpi. After infection,  glucose  
consumption  increased when cells reached class IV of infection, all available 
glucose had been consumed, during harvests, media was replaced, and 
glucose was supplied, even though all glucose was consumed. This result may 
be explained because rabies virus is a glycoprotein, and glucose was used to 
produce it. Since first dpi, virus titer met vaccine production requirement. In this 
study, VPD infection reached highest virus titer and highest average of virus 
titer (Table 5). This cultivation was the only where maximal cell density has not 
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Infection Kinetics - VPD 
 
Cell density x Virus titer - VPD 
 
FIGURE 23 – INFECTION BEHAVIOR, CELL GROWTH AND METABOLISM AFTER RABIES 
VIRUS INFECTION (A), AND VIRUS PRODUCTION (B) OF CELLS ADAPTED TO VP-SFM BY 
DIRECT MEDIA CHANGE. 
 
ExD infection presented maximal cell density 3 dpi (Figure 24A). A slight 
decrease of cell viability was observed right after cell infection. Virus titer peak 
(bold in Table 5) coincided with maximal cell density (Figure 24B) and when 
more than 75% of cells were infected. Glucose consumption and lactate 
production increased after infection, but glucose scarcity was not observed. 
Only first harvest has not reached minimal virus titer for vaccine production. 
ExG infection reached maximal cell density on fourth dpi (Figure 25A). A 
slight decrease of cell viability was observed right after cell infection. Infection 
class IV was obtained on second day after infection. Virus titer peak (Table 5) 
coincided with maximal cell density (Figure 25B). Glucose consumption and 
lactate production increased after infection, but glucose scarcity was observed 
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Infection Kinetics - ExD
 
Cell density x Virus titer - ExD
 
FIGURE 24 - INFECTION BEHAVIOR, CELL GROWTH AND METABOLISM AFTER RABIES 
VIRUS INFECTION (A), AND VIRUS PRODUCTION (B) OF CELLS ADAPTED TO EX CELL 
302 BY DIRECT MEDIA CHANGE. 
Infection Kinetics - ExG 
 
Cell density x Virus titer - ExG 
 
FIGURE 25 - INFECTION BEHAVIOR, CELL GROWTH AND METABOLISM AFTER RABIES 
VIRUS INFECTION (A), AND VIRUS PRODUCTION (B) OF CELLS ADAPTED TO EX CELL 
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CVTDvp infection presented maximal cell density 5 days post infection 
(Figure 26A). A high decrease of cell viability was observed right after cell 
infection. Virus titer peak (bold in Table 5) coincided with maximal total cell 
density, at fourth dpi, and with maximal viable cell density, on 5 dpi (Figure 
26B). One day after infection, less than 25% of cells were infected. Only on third 
dpi more than 75% of cells were infected. Glucose consumption and lactate 
production increased after infection. Glucose scarcity was only observed at 
sixth harvest. First harvest was the only that did not reached minimal virus titer 
for vaccine production. 
 
Infection Kinetics - CVTDvp 
 
Cell density x Virus titer - CVTDvp 
 
FIGURE 26 - INFECTION BEHAVIOR, CELL GROWTH AND METABOLISM AFTER RABIES 
VIRUS INFECTION (A), AND VIRUS PRODUCTION (B) OF CELLS ADAPTED TO 
CELLVENTO BHK-200 BY DIRECT MEDIA CHANGE. 
 
 
CVTGvp infection presented maximal cell density 4 days post infection 
(Figure 27A), coinciding with virus titer peak (Figure 27B). A high decrease of 
cell viability was observed right after cell infection. One day after infection, less 
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on third dpi. Glucose consumption and lactate production increased after 
infection, but glucose scarcity was only observed at sixth harvest. Only first 
harvest has not reached minimal virus titer for vaccine production. 
 
 
Infection Kinetics - CVTGvp 
 
Cell density x Virus titer - CVTGvp 
 
 
FIGURE 27- INFECTION BEHAVIOR, CELL GROWTH AND METABOLISM AFTER RABIES 
VIRUS INFECTION (A), AND VIRUS PRODUCTION (B) OF CELLS ADAPTED TO 
CELLVENTO BHK-200 BY GRADUAL MEDIA CHANGE. 
 
Figure 28 shows virus titer during infection kinetics of 6 studies. With 
exception of VPD, that had all harvests with virus titer meeting requirements for 
vaccine production, others presented enough virus titer since second dpi.  
No relation was observed between infection class and virus titer, since, 
even when less than 50% of cells were infected, virus titer was higher than 
103.8. All adapted cells showed capacity to produce virus for vaccine production.  
Cell adapted to VP culture media, presented worst growth kinetic, but best 
virus production, demonstrating the importance of virus infection study. VP is a 
culture media developed to virus production, and probably presents formulation 
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investigate if increasing glucose supply during infection would enhance virus 
production.  
 
Comparison of virus production 
          
FIGURE 28 - COMPARISON OF VIRUS PRODUCTION OF ALL ADAPTED CELL LINES.  
Red line is cut off line. Only results above read line are used for vaccine production 
 
 
Results presented indicate that adapted to serum free cells can produce 
rabies virus for vaccine production. However, virus harvests have to formulated 
and challenged in animals to confirm vaccine potency. 
Perrin et al17 carried out cell infection in bioreactor using perfusion system. 
Best virus titer were achieved from third to fifth days after infection. Results of 
this study have presented high virus titer from second until sixth day post 
infection. 
Kalel et al19 infected BHK-21 adapted to serum free media with rabies 
virus. Study was carried out in spinners. Virus titer started to increase after 
three and five days post infection, depending on media used. Virus peaks were 
obtained on ninth dpi.  
Although cells adapted to VP-SFM culture media showed best virus titers 
results, attention should be paid to Cellvento BHK-200 culture media. As this 
culture media was developed to veterinary vaccine, mainly mouth-and-foot 
decease, that requires large scale production and very low prices, when 
compared to human vaccines, Cellvento BHK-200 price is about ten times 
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vaccine production (VP-SFM), or for recombinant proteins for human use (Ex 
Cell 302).  
Table 6 shows a comparison of culture media costs using serum free 
media to produce 10 millions of doses of rabies vaccine. So, until this moment, 
Cellvento BHK-200 is culture media seems to be the most adequate for 
veterinary rabies vaccine production. 
 
TABLE 6 – COST ESTIMATION OF SERUM FREE CULTURE MEDIA FOR 10 MILLION OF 
DOSES OF VACCINE PRODUCTION. 
Culture medium Volume for 10 million of 
doses 
Medium costs (EUR) 
VP-SFM 10,000 L 400,000.00 
Ex Cell 302 11,000L 440,000.00 





5. Conclusion  
BHK-21 C13 cell in suspension was able to adapt in the three serum free 
culture media used in this study (VP-SFM, Ex-Cell 302 and Cellvento BHK-
200). Kinetics studies of cell growth and rabies virus production demonstrated 
that best results in growth kinetics does not mean best results in virus 
production. All adapted cells are able to produce rabies virus for vaccine 
production. Different adaptation protocols do not interfere on results of virus 
production. Best virus productivity was reached using VP-SFM culture media, 
however, taking into account economic aspects, best result achieved was by 
using Cellvento BHK-200.  
Vaccine potency must be determined to prove virus quality. Since vaccine 
potency is good, scale up studies using serum free media should be carried out 
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